Travere Therapeutics stock hits 52-week high at 37.12 USD By Investing.com - Stock Watch Index

Travere Therapeutics stock hits 52-week high at 37.12 USD By Investing.com

November 28, 2025

Travere Therapeutics stock hits 52-week high at 37.12 USD

Search

RECENT PRESS RELEASES

Renn fund president Stahl buys shares worth $2891 By Investing.com

SWI Editorial Staff2025-11-28T09:20:11-08:00November 28, 2025|

Meta Questions Scope of EU Regulators’ Power in Antitrust Probes

SWI Editorial Staff2025-11-28T09:19:28-08:00November 28, 2025|

Amundi Launches Its First Tokenized Money Market Fund on Ethereum

SWI Editorial Staff2025-11-28T09:18:55-08:00November 28, 2025|

Avail Launches Nexus Mainnet, Unifies Liquidity Across Ethereum, Solana, EVMs

SWI Editorial Staff2025-11-28T09:18:39-08:00November 28, 2025|

Amundi Goes On-Chain With Euro Cash Fund as ETH/BTC Signals a Major Upside Move

SWI Editorial Staff2025-11-28T09:18:07-08:00November 28, 2025|

Avail Launches Nexus Mainnet, Unifies Liquidity Across Ethereum, Solana, EVMs

SWI Editorial Staff2025-11-28T09:17:40-08:00November 28, 2025|

Related Post